Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $73.3700 (-2.34%) ($72.5500 - $75.4400) on Fri. Apr. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 49 | Latest Price | $73.3700(-2.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(56%) SPLV(43%) VYM(41%) DIA(40%) IVE(39%) | Factors Impacting ABBV price | ABBV will decline at least -1.665% in a week (0% probabilities). VIXM(-28%) UUP(-11%) VXX(-9%) TLT(-5%) UNG(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | -0.2 () | Intraday Trend | -1.8% | | | |
|
Inflection Point | Yes | Resistance Level | $74.76 | 5 Day Moving Average | $74.67(-1.74%) | 10 Day Moving Average | $72.16(1.68%) | 20 Day Moving Average | $74.76(-1.86%) | To recent high | -25% | To recent low | 13.8% | Market Cap | $129.445b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |